SS-31 50 mg

SS-31 50 mg – Mitochondria-Targeting Peptide for Research | Peptide Hubs

SS-31 (also known as Elamipretide) is a mitochondria-targeted tetrapeptide investigated for its unique ability to preserve and restore mitochondrial function. Peptide Hubs offers this powerful compound in a 50 mg (2 mL) vial, designed for laboratory use in studies focused on cellular energy, oxidative damage, neurodegeneration, and age-related tissue decline.

What is SS-31?

SS-31 is a synthetic peptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that penetrates mitochondria and binds to cardiolipin, a lipid critical for mitochondrial integrity. Its primary mechanism involves reducing mitochondrial ROS (reactive oxygen species) while enhancing ATP production. In preclinical studies, SS-31 has demonstrated potential in improving cardiac, muscular, neural, and renal function.

According to recent findings published in PubMed, SS-31 may reduce age-related decline and organ dysfunction by enhancing mitochondrial bioenergetics and minimizing oxidative stress in critical tissues.

Potential Research Applications

• Neurodegeneration (e.g., Parkinson's, Alzheimer's models)
• Age-related macular degeneration (AMD)
• Heart failure and myocardial ischemia models
• Renal protection during acute kidney injury
• Muscular atrophy, fatigue, and mitochondrial myopathy

Recommended Research Dosage & Protocol

In experimental settings, SS-31 is typically dosed between 10 mg to 25 mg per week, administered subcutaneously or intraperitoneally in animal models. Its effects have been observed even with short-term protocols of 7–14 days, depending on the research focus. It is important to use sterile, research-grade solvents during reconstitution for optimal performance.

Stacking Options for Advanced Studies

SS-31 is frequently stacked with other cellular repair peptides to expand therapeutic targets:

• BPC-157 – promotes tissue repair and reduces inflammation
• GHK-Cu – for regenerative and anti-aging research
• AOD-9604 – for fat metabolism and metabolic protection
• Thymosin Beta-4 – for angiogenesis and cardiovascular protection

Safety Profile and Side Effects (in Research Models)

SS-31 has shown excellent tolerability in preclinical and early human studies. No hormonal, hepatic, or renal toxicity has been reported in existing data. It does not affect androgenic or estrogenic pathways. Transient redness or mild irritation at the injection site may occur but resolves quickly with proper handling.

USA Domestic Shipping – Trusted Quality from Peptide Hubs

Peptide Hubs ensures fast USA domestic shipping of SS-31 50 mg and all peptide products. Each vial is manufactured under strict GMP standards and labeled for research use only. Explore related products like CJC-1295 DAC or Ipamorelin for complete anti-aging and metabolic study solutions.

Frequently Asked Questions